Delivery Order SPE2DB24D2213-SPE2DB24FGVMX
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,744.43 delivery order is for the supply of GARDASIL 9 syringes, a vaccine product, to support military treatment facilities and healthcare programs. The contract has an ultimate completion date of August 7, 2024 and is a firm fixed-price delivery order. Amerisourcebergen, as one of the largest pharmaceutical distributors in the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $12,246.53 firm fixed price delivery order is for the supply of GARDASIL 9 syringes, a pharmaceutical product, with a performance period through March 2024. This award is part of a larger indefinite delivery contract (IDC) valued up to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,451.92 Firm Fixed Price delivery order is for the supply of GARDASIL 9 vaccine syringes. The contract has a July 11, 2024 completion date and is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,520.37 firm fixed price delivery order is for the supply of GARDASIL 9 syringes, a vaccine product. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,795.54 delivery order is for the supply of GARDASIL 9 syringes, a vaccine product. The contract has a fixed-price structure and a completion date of June 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $31,663.92 firm fixed price delivery order is for the supply of GARDASIL 9 SYRINGE 10S, a pharmaceutical product. The award has a completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $7,442.58 firm fixed price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,056.86 Firm Fixed Price Delivery Order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, with a period of performance through September 9, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, has been awarded this contract to provide essential medical commodities to...
This federal contract award, valued at $6,467.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GARDASIL 9 syringes, a vaccine product, with a completion date of September 9, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,274.75 firm-fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...